The Baroness Greenfield | |
---|---|
![]() | |
Born | Susan Adele Greenfield 1 October 1950 |
Alma mater | St Hilda's College, Oxford |
Spouse | [3] |
Awards | CBE, Knight of the Legion of Honour |
Scientific career | |
Institutions | |
Thesis | Origins of acetylcholinesterase in cerebrospinal fluid (1977) |
Doctoral advisor | Anthony David Smith[1] |
Website | www |
Susan Adele Greenfield, Baroness Greenfield, CBE, FRCP[4] (born 1 October 1950) is an English scientist, writer, broadcaster and member of the House of Lords (since 2001). Her research has focused on the treatment of Parkinson's disease and Alzheimer's disease. She is also interested in the neuroscience of consciousness[5] and the impact of technology on the brain.[6]
Greenfield is a senior research fellow at Lincoln College, Oxford;[7] she was a professor of Synaptic Pharmacology.[citation needed]
Greenfield was chancellor of Heriot-Watt University in Edinburgh between 2005 and 2013.[8] From 1998 to 2010, she was director of the Royal Institution of Great Britain.[9] In September 2013, she co-founded the biotech company Neuro-bio Ltd, where she is chief executive officer.
greenfieldphd
was invoked but never defined (see the help page).ind08
was invoked but never defined (see the help page).